PeptiDream Inc. (TYO:4587)

Japan · Delayed Price · Currency is JPY

1,481.00

+70.50 (5.00%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018
Drug Discovery and Development Business	2.79B	31.31B	12.70B	15.41B	9.37B
Drug Discovery and Development Business Growth	-91.08%	146.50%	-17.55%	64.49%	-19.79%
Unallocated Adjustments	-1.15B	-740.69M	-86.96M	-27.18M	-
Radioactive Pharmaceutical Business	16.88B	16.10B	16.10B	11.47B	-
Radioactive Pharmaceutical Business Growth	4.81%	0.05%	40.29%	-	-
Total	18.52B	46.68B	28.71B	26.85B	9.37B
Total Growth	-60.32%	62.57%	6.93%	186.70%	-19.79%

Revenue by Geography

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018
Japan	15.57B	18.98B	11.39B	-
Japan Growth	-17.97%	66.68%	-	-
United States of America	1.42B	7.95B	13.81B	-
United States of America Growth	-82.16%	-42.43%	-	-
Europe	29.38B	1.47B	1.44B	-
Europe Growth	1896.14%	2.05%	-	-
Other	311.48M	309.30M	211.19M	-
Other Growth	0.70%	46.45%	-	-
Total	46.68B	28.71B	26.85B	-
Total Growth	62.57%	6.93%	-	-

Source: S&P Global Market Intelligence.